Your browser doesn't support javascript.
loading
Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: metabolomics-informed genomics.
Liu, Duan; Ray, Balmiki; Neavin, Drew R; Zhang, Jiabin; Athreya, Arjun P; Biernacka, Joanna M; Bobo, William V; Hall-Flavin, Daniel K; Skime, Michelle K; Zhu, Hongjie; Jenkins, Gregory D; Batzler, Anthony; Kalari, Krishna R; Boakye-Agyeman, Felix; Matson, Wayne R; Bhasin, Swati S; Mushiroda, Taisei; Nakamura, Yusuke; Kubo, Michiaki; Iyer, Ravishankar K; Wang, Liewei; Frye, Mark A; Kaddurah-Daouk, Rima; Weinshilboum, Richard M.
Affiliation
  • Liu D; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.
  • Ray B; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.
  • Neavin DR; Current affiliation: Assurex Health Inc, Mason, OH, USA.
  • Zhang J; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic Graduate School of Biomedical Sciences, School of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Athreya AP; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.
  • Biernacka JM; Current affiliation: PreventionGenetics LLC, Marshfield, WI, USA.
  • Bobo WV; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.
  • Hall-Flavin DK; Department of Electrical and Computer Engineering, University of Illinois at Urbana-Champaign, Urbana, IL, USA.
  • Skime MK; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Zhu H; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
  • Jenkins GD; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
  • Batzler A; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
  • Kalari KR; Department of Psychiatry and Behavioral Medicine, Duke University, Durham, NC, USA.
  • Boakye-Agyeman F; Department of Medicine, Duke University, Durham, NC, USA.
  • Matson WR; Duke Institute for Brain Sciences, Duke University, Durham, NC, USA.
  • Bhasin SS; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Mushiroda T; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Nakamura Y; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Kubo M; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.
  • Iyer RK; Current affiliation: Department of Pharmacometrics, Duke Clinical Research Institute, Durham, NC, USA.
  • Wang L; Department of Systems Biochemistry, Bedford VA Medical Center, Bedford, MA, UK.
  • Frye MA; Current affiliation: Ixcela, Inc, Bedford, MA, UK.
  • Kaddurah-Daouk R; Department of Systems Biochemistry, Bedford VA Medical Center, Bedford, MA, UK.
  • Weinshilboum RM; Current affiliation: Ixcela, Inc, Bedford, MA, UK.
Transl Psychiatry ; 8(1): 10, 2018 01 10.
Article in En | MEDLINE | ID: mdl-29317604

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Aryl Hydrocarbon / Beta-Defensins / Depressive Disorder, Major / Basic Helix-Loop-Helix Transcription Factors / Kynurenine Type of study: Prognostic_studies Limits: Humans Language: En Journal: Transl Psychiatry Year: 2018 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Aryl Hydrocarbon / Beta-Defensins / Depressive Disorder, Major / Basic Helix-Loop-Helix Transcription Factors / Kynurenine Type of study: Prognostic_studies Limits: Humans Language: En Journal: Transl Psychiatry Year: 2018 Document type: Article